Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
07 Oct 2024 |
CS01 |
Confirmation statement made on 6 October 2024 with no updates
|
|
|
04 Oct 2024 |
AA |
Full accounts made up to 31 December 2023
|
|
|
02 Oct 2024 |
AP01 |
Appointment of Amanda Flanagan as a director on 1 October 2024
|
|
|
01 Oct 2024 |
TM01 |
Termination of appointment of Samantha Jane Laura Pearce as a director on 1 October 2024
|
|
|
01 Oct 2024 |
AD01 |
Registered office address changed from Wing B, Building 5700, Spires House John Smith Drive Oxford Business Park South Oxford OX4 2RW to 80 Charlotte Street London W1T 4DF on 1 October 2024
|
|
|
18 Apr 2024 |
AP03 |
Appointment of Alkesh Patel as a secretary on 3 April 2024
|
|
|
18 Apr 2024 |
TM02 |
Termination of appointment of Aislinn Jane Doody as a secretary on 3 April 2024
|
|
|
16 Oct 2023 |
AA |
Full accounts made up to 31 December 2022
|
|
|
09 Oct 2023 |
CS01 |
Confirmation statement made on 6 October 2023 with updates
|
|
|
03 Jan 2023 |
SH01 |
Statement of capital following an allotment of shares on 13 December 2022
|
|
|
03 Jan 2023 |
MA |
Memorandum and Articles of Association
|
|
|
16 Dec 2022 |
SH19 |
Statement of capital on 16 December 2022
|
|
|
16 Dec 2022 |
CAP-SS |
Solvency Statement dated 13/12/22
|
|
|
16 Dec 2022 |
SH20 |
Statement by Directors
|
|
|
16 Dec 2022 |
RESOLUTIONS |
Resolutions
-
RES06 ‐
Resolution of reduction in issued share capital
-
RES10 ‐
Resolution of allotment of securities
-
RES13 ‐
Cancel share premium account 13/12/2022
-
RES14 ‐
Capitalise £62,558,992 13/12/2022
-
RES01 ‐
Resolution of alteration of Articles of Association
|
|
|
12 Oct 2022 |
AA |
Full accounts made up to 31 December 2021
|
|
|
06 Oct 2022 |
CS01 |
Confirmation statement made on 6 October 2022 with updates
|
|
|
10 May 2022 |
PSC02 |
Notification of Jazz Pharmaceuticals Uk Holdings Limited as a person with significant control on 5 April 2022
|
|
|
10 May 2022 |
PSC07 |
Cessation of Jazz Pharmaceuticals Lux Sarl as a person with significant control on 5 April 2022
|
|
|
04 Nov 2021 |
AP01 |
Appointment of Nelly Lepelletier as a director on 2 November 2021
|
|
|
04 Nov 2021 |
TM01 |
Termination of appointment of Bridget Mary O'brien as a director on 2 November 2021
|
|
|
04 Nov 2021 |
TM01 |
Termination of appointment of Hugh Kiely as a director on 2 November 2021
|
|
|
08 Oct 2021 |
CS01 |
Confirmation statement made on 6 October 2021 with no updates
|
|
|
22 Sep 2021 |
AA |
Full accounts made up to 31 December 2020
|
|
|
15 Dec 2020 |
AP01 |
Appointment of Samantha Pearce as a director on 9 December 2020
|
|